Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Amdocs Limited (DOX) Investigation

DOX

NEW YORK, NY / ACCESSWIRE / April 5, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amdocs Limited("Amdocs" or "the Company") (NASDAQ:DOX). Investors who purchased Amdocs securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/dox.

The investigation concerns whether Amdocs and certain of its officers and/or directors have violated federal securities laws.

On March 31, 2021, pre-market, Jehoshaphat Research published a short-seller report addressing Amdocs, which alleged, among other things, that: (1) Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; (2) there was a concerning pattern of reputable auditors resigning, only to be replaced by "scandal-plagued or tiny shops"; (3) Amdocs "window-dressed" its balance sheets to keep its large borrowing a secret; and (4) all of the foregoing was corroborated by former employees and direct competitors of the Company, including a former American Amdocs executive, who stated that the Company's "US business was declining at a rate of [around] 7% annually...but then we would see the company [publish results that] say North America is stable." On this news, Amdocs' stock price fell sharply during intraday trading on March 31, 2021.

If you are aware of any facts relating to this investigation, or purchased Amdocs shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/dox. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/638448/Bronstein-Gewirtz-Grossman-LLC-Notifies-Investors-of-Amdocs-Limited-DOX-Investigation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today